课题基金 / 基金详情

Small Animal Imaging Core

Small Animal Imaging Core
小动物成像核心
批准号:
8382075
负责人:
Craig J Galban
金额:
$22.07万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
已结题
起止时间:
至 2014-08-31

项目摘要

项目成果

Craig J Galban的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
CORE B: The Animal Imaging Core will assist will all of the imaging studies and analysis of cells, tissue specimens and mouse tumor models for all projects. Core personnel will provide these services: (a) define and implement data acquisition/imaging sequences; (b) assist with animal preparation for imaging; (c) perform all data collection on CM I imaging systems; (d) data processing, image reconstruction and image registration; (e) security archival of raw data and network transfer of reconstructed data to the Digital Image Processing Laboratory; (f) scheduling of imaging experiments; and (g) provide support to Program Investigators in technical design of imaging experiments. These services designed, in part, after a "clinical imaging service" model since continual, high-volume animal scanning is essential for success the diverse ICMIC Projects. More than 2400 hours of bioluminescence, fluorescence and MR imaging will be performed over five years. Dr. Galban will serve as Core B Director. Dr. Galban has extensive experience in small animal imaging research. A Laboratory manager and the DIPL director will aid with day-to-day operations and technique development. Technician support will be provided by the Center for Molecular Imaging (CMI). Public Health: Overall/this Core will provide the required services for forwarding the overall mission of this ICMIC application to develop molecular imaging tools and applications for ultimately impacting patient care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients
Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients
Prediction of COPD Progression by PRM
Prediction of COPD Progression by PRM
海外基金